E bradykinin. The nonapeptide has a very short half-life (a matter of seconds) and exhibits its functions via the B1 and B2 receptors (3). Generating other mediators such as nitric oxide, prostaglandins, and leukotrienes, bradykinin is involved in the regulation of blood pressure, the induction of fever and pain, vascular leakage, and the chemotaxis of immune cells (4). In addition, further proces

E bradykinin. The nonapeptide has a very short half-life (a matter of seconds) and exhibits its functions via the B1 and B2 receptors (3). Generating other mediators such as nitric oxide, prostaglandins, and leukotrienes, bradykinin is involved in the regulation of blood pressure, the induction of fever and pain, vascular leakage, and the chemotaxis of immune cells (4). In addition, further proces

Ver the age of 65. Interestingly, there is no significant difference between the non frail and frail groups of patients admitted to intensive care. This may be because of small sample size. The length of stay of the frail patient is shorter and this may be because as intensivists we are better at treatment limitation in this group of patients. No difference in overall mortality suggests that the p

What's an Insurance Broker? This term can be used to describe anybody that offers insurance.

Ver the age of 65. Interestingly, there is no significant difference between the non frail and frail groups of patients admitted to intensive care. This may be because of small sample size. The length of stay of the frail patient is shorter and this may be because as intensivists we are better at treatment limitation in this group of patients. No difference in overall mortality suggests that the p

Ver the age of 65. Interestingly, there is no significant difference between the non frail and frail groups of patients admitted to intensive care. This may be because of small sample size. The length of stay of the frail patient is shorter and this may be because as intensivists we are better at treatment limitation in this group of patients. No difference in overall mortality suggests that the p

Ithout malignancy [53].Non anti-infectious agentsG-CSF and GM-CSFHaemopoietic growth factors, such as granulocyte colonystimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been assessed in several clinical trials [54,55]. The known effect of G-CSF and GM-CSF in increasing the number of circulating neutrophil granulocytes was the rationale for clinical stud

Ared the frail population to the non-frail population. Results: Two hundred and eighty four patients were admitted to Intensive Care in this time period. Of those, 102 were over the age of 65 years. Of the 102 patients, 68patients were deemed to be frail, and 34 were deemed to be non-frail using the CFS. Approximately 40 of the patients admitted to Intensive Care are over the age of 65. There wa